An all-day "think tank" to consider priorities for amyotrophic lateral sclerosis (ALS) research based on the latest information was conducted with ten of the leading scientists and clinicians in the field and senior MDA staff in Tucson, Ariz., on Saturday, Oct. 24, 2009.
Each specialist introduced his or her area of expertise and led an approximately 20-minute discussion, gathering input and answering questions from the other participants.
The topics included explorations of the state of current knowledge about several aspects of ALS, the contributions of each aspect, and some ideas about therapeutic targets.
Discussions covered the cutting-edge of ALS research:
|Neurologist Valerie Cwik, senior executive vice president-research and medical director at MDA, and neurologist Stan Appel, a longtime MDA research grantee and director of the MDA/ALS Center at Methodist Neurological Institute in Houston, at the Oct. 24 meetin|
As a result of this session and follow-up communications among the attendees, a prioritized list of research directions will be created.
Participants in the meeting were Jinsy Andrews, Stanley Appel, Robert Baloh, Merit Cudkowicz, Jonathan Glass, Michio Hirano, Robert Miller, Timothy Miller, Hiroshi Mitsumoto and Jeffrey Rothstein.